🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase III non-inferiority trial targeting a specific subset...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07432178
Treatments Being Tested
High tibial osteotomy (HTO) surgical procedure can lead to clinically signi...
Status
Completed
Location
Stefano Zaffagnini
Start Date
2021-05-17
Trial ID
NCT05865899
Treatments Being Tested
This study will evaluate the pharmacokinetics (area under the curve \[AUC\]...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT02864199
Treatments Being Tested
Neutropenia, a condition characterized by an abnormally low number of infec...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2008-04
Trial ID
NCT00627393
Treatments Being Tested
The purpose of this study is to determine efficacy of treatment with bortez...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00872521
Treatments Being Tested
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested
The hypotheses of the study are * There will be differences in perceived p...
Status
Completed
Location
University of Gujrat
Start Date
2023-08-15
Trial ID
NCT06001021
Multicenter, prospective, open-labeled, 2-arm, non-comparative randomized p...
Status
Completed
Location
Institut Bergonié
Start Date
2022-02-09
Trial ID
NCT04807816
Treatments Being Tested
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested